- Home
- XNET vs INMB Comparison
XNET vs INMB Comparison
Compare XNET & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNET | INMB |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.4M | 40.4M |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XNET | INMB |
|---|---|---|
| Price | $5.87 | $1.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 139.3K | ★ 364.9K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.29 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $4.02 | $1.09 |
| 52 Week High | $11.03 | $11.64 |
Technical Indicators
Market Signals| Indicator | XNET | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 44.25 | 57.51 |
| Support Level | $5.90 | $1.38 |
| Resistance Level | $6.12 | $1.71 |
| Average True Range (ATR) | 0.27 | 0.11 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 24.99 | 54.17 |
Price Performance
Historical ComparisonAbout XNET Xunlei Limited
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.